We are live on ! Find out more
NNVC icon

NanoViricides

32 hedge funds and large institutions have $2.01M invested in NanoViricides in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more call options, than puts

Call options by funds: $49K | Put options by funds: $23K

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

0.02% less ownership

Funds ownership: 11.38%11.35% (-0.02%)

6% less funds holding

Funds holding: 3432 (-2)

13% less capital invested

Capital invested by funds: $2.31M → $2.01M (-$299K)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
32
Holders Change
-2
Holders Change %
-5.88%
% of All Funds
0.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
5
Closed
5
Calls
$49K
Puts
$23K
Net Calls
+$26K
Net Calls Change
-$8K

NNVC Hedge Fund Activity: Q3 2024 in Review

32 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q3 2024, worth a combined $2.01M — down 13% from $2.31M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of NNVC and 3 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 6 added.

The largest buyer was Integrated Wealth Concepts, adding an estimated $30.6K. The largest seller was Bridgeway Capital Management, cutting an estimated $27.8K.

  • 32 institutional investors held NanoViricides (NNVC) as of Q3 2024, down from 34 in Q2 2024.
  • Funds reported $2.01M of NanoViricides stock for Q3 2024, down 13% quarter-over-quarter.
  • 3 funds opened new NanoViricides positions in Q3 2024 and 5 closed out, a net change of -2 holders.
  • The largest NanoViricides buyer in Q3 2024 was Integrated Wealth Concepts, an estimated $30.6K added.
  • The largest NanoViricides seller in Q3 2024 was Bridgeway Capital Management, an estimated $27.8K sold.

Based on aggregated 13F filings for Q3 2024.